Aim: Existing evidence suggests that endothelial lipase (EL) plays an important role in high-densitylipoprotein (HDL) metabolism. Because rabbits are a useful animal model for the study of human lipid metabolism and atherosclerosis, we characterized rabbit EL (rEL) expression and investigated its relationship with plasma HDL levels in normal and hyperlipidemic rabbits. Methods: We cloned the rEL cDNA and analyzed the EL tissue expression using Northern blotting, real-time RT-PCR, Western blotting, and in situ hybridization. We evaluated the effects of rEL antisense on plasma HDL levels. Results: We found that rEL mRNA was highly expressed in cholesterol synthesis-related organs, including the liver, testis, and adrenal along with its expression in the lung, kidney, bone marrow, and small intestine. Interestingly, Watanabe heritable hyperlipidemic (WHHL) rabbits, a model of human familial hypercholesterolemia, had lower plasma levels of HDLs than normal rabbits. The plasma HDL levels in WHHL rabbits were inversely associated with high levels of plasma rEL proteins and hepatic expression of rEL mRNA. Injection of rEL-specific antisense oligonucleotides into rabbits resulted in the elevation of plasma large HDLs. Furthermore, we demonstrated that rEL mRNA was expressed by both endothelial cells and macrophages in the lesions of aortic atherosclerosis of WHHL rabbits. Conclusions: rEL is expressed in multiple tissues and may have many physiological and pathophysiological functions, such as in the regulation of cholesterol metabolism and atherosclerosis. Our results suggest that EL is an important regulator of plasma HDL levels in rabbits. 
Introduction
Endothelial lipase (EL), which was discovered independently by two laboratories in 1999 1, 2) , belongs to the triglyceride lipase family, including lipoprotein lipase (LPL) and hepatic lipase (HL). Despite high many possibilities for the study of human lipoprotein metabolism and atherosclerosis 14, 15) . We envision that investigation of the possible role of EL in atherosclerosis using transgenic rabbits with overexpression and/or deletion of the EL gene will provide valuable insights into the pathogenesis of the disease. Towards this undertaking, it is essential to determine the rabbit endogenous EL expression and physiological functions in vivo. In the current study, we cloned rEL cDNA, assembled/annotated the protein from the genomic structure of the gene, and investigated the tissue distribution of rEL mRNA expression patterns in different tissues in rabbits. Our studies showed that EL is expressed in multiple tissues and mediates the plasma levels of HDLs in rabbits. rEL was expressed in the lesions of aortic atherosclerosis of WHHL rabbits.
Materials and Methods

Rabbits
Normal Japanese white (JW) rabbits and myocardial infarction-prone Watanabe heritable hyperlipidemic (WHHLMI) rabbits were used for the current study as described previously 14, 15) . The tissues from different parts of rabbits were freshly collected for RNA and protein extraction, as well as in situ hybridization and immunohistochemical staining (see below). This study was approved by the Animal Care Committee of the University of Yamanashi and conformed to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health.
Rabbit EL cDNA Cloning and Expression Analysis
Total RNA was extracted from rabbit tissues using TRIzol reagent (Invitrogen, Carlsbad, CA). First-strand cDNA was generated by the SuperScript Ⅲ First-Strand Synthesis System (Invitrogen) with random primers, following the manufacturer's instructions. The cDNA served as a template for rabbit EL (rEL) cloning. Using human EL mRNA sequences (accession No: NM_006033), we performed a BLAST search against the rabbit genome trace archive database (Oryctolagus cuniculus-WGS) provided by the National Center for Biotechnology Information. On the basis of the alignment results, we first assembled an electronic version of the putative rEL mRNA sequence including 5'UTR, cds, and 3'UTR. To clone rEL cDNA, we designed several pairs of primers for RT-PCR with PfuUltra high-fidelity DNA polymerase (Agilent Technologies, Inc., Santa Clara, CA). The amplified DNA was recovered from agarose gel using a QIAquick Gel Extraction kit (Qiagen, Valencia, CA) sequence similarities, the members of this family have different relative preferences for lipid substrates. EL has high phospholipase activity but low triglyceride lipase activity, which is opposite to the low phospholipase activity and high triglyceride lipase activity of LPL. On the other hand, HL hydrolyzes triglycerides and phospholipids equally 3) . Compelling evidence suggests that EL plays an important role in HDL metabolism 3, 4) . In EL knock-out (KO) mice, deletion of the EL gene resulted in increased plasma levels of HDL-cholesterol (HDL-C), whereas overexpression of the human EL gene led to the reduction of HDL-C levels in EL transgenic mice 5) . Moreover, clinical studies revealed that the plasma EL mass is inversely associated with plasma HDL-C levels, and a high level of EL proteins correlates with inflammation, metabolic syndrome, and coronary atherosclerosis 6) . In addition to HDL metabolism, EL is involved in apoB-containing lipoprotein metabolism 7) . These findings suggest that inhibition of EL would elevate HDL-C levels. On the other hand, EL may directly or indirectly participate in the pathogenesis of atherosclerosis through catalytic and non-catalytic "bridging" functions, although this hypothesis has not been definitively verified. EL inactivation was found to be anti-atherogenic in apo-E KO mice 8) but this was not confirmed by other studies 9) , even though EL immuno-reactive proteins were found in human atherosclerotic lesions 10) . Therefore, it remains to be clarified whether EL is anti-atherogenic or pro-atherogenic in mouse models. The major concern regarding whether inhibition of EL activity is potentially beneficial for the treatment of atherosclerosis was raised from the finding that deletion of the EL gene in KO mice also resulted in the elevation of LDL in addition to HDL 5, 8) .
Because there are many differences in lipid metabolism and the cardiovascular system between humans and mice, it may not be adequate to use mouse models to verify EL-inhibition therapeutic effects for humans. There is a need to develop alternative non-murine animal models to elucidate EL functions in vivo 11) . Rabbits are a useful animal model for the study of human lipid metabolism and atherosclerosis because they can easily develop hypercholesterolemia and atherosclerosis on a cholesterol diet, and the lesions of atherosclerosis of both the aorta and coronary arteries resemble human atherosclerotic pathology 12, 13) . Like humans, but unlike mice, rabbits have abundant plasma CETP and exhibit hepatic apoB100 and intestinal apoB48 synthesis, and their lipoprotein profiles are LDL-rich 13) . The suitability of Watanabe heritable hyperlipidemic (WHHL) rabbits, a model of human familial hypercholesterolemia, has provided
FISH Mapping of rEL Gene on G-Banded Rabbit Chromosomes
Fluorescence in situ hybridization (FISH) analysis was performed on cultured rabbit fibroblasts to determine the chromosomal localization of the rEL gene as previously described 18) . In brief, rabbit embryos were collected at day 13-14 of gestation and a piece of the skin was minced and digested using a solution of 0.25% trypsin and 0.25 mM EDTA for 30 min at 37 ℃. The cells were cultured in T75 flasks in Dulbecco's modified Eagle's medium (DMEM) with high glucose (4.5 g/L) supplemented with 10% fetal and cloned into pCR4Blunt-TOPO (Invitrogen). Then, several random clones from each PCR product were collected and sequenced with M13 forward and reverse primers. The rEL mRNA sequences were finally assembled. For Northern blotting analysis, 10 μg total RNA from each tissue was fractionated on a 1.2% agarose gel and then transferred to nylon membranes, which were hybridized with a 32 P-labeled rEL cDNA probe at 68 ℃ for 16 h. After hybridization, the membranes were washed at 65 ℃ in the presence of 0.1% SSC and 0.1% SDS. Visualization was achieved by exposure to a BAS-2500 IP Reader (Fujifilm, Tokyo, Japan). The mRNA levels of the rEL were also evaluated by quantitative real-time RT-PCR using a SYBR ® Premix Ex Taq TM kit (Takara Bio Inc., Tokyo) according to the manufacturer's instructions 14) . The primers are listed in Table 1 .
Generation of Polyclonal Antibody Against rEL
A peptide corresponding to rEL #469-490 amino acids (KTSIAPGQELWFYKCRDGWRMK) was synthesized and used as an antigen to immunize rabbits for the generation of polyclonal Abs, which was performed by YenZym Antibodies, LLC (South San Francisco, CA). This rEL Ab can detect rEL proteins expressed by transfected 293 cells but showed no cross-reaction with human EL proteins (Fig. 1) . Immuno-reactive rEL proteins in the post-heparin plasma and liver were investigated by Western blotting, as described previously with some modifications 16, 17) . The membrane was probed with anti-rEL Ab (1:200) for 16 hours at 4 ℃ and then washed three times. Immunocomplexed proteins were then identified by reaction with horseradish peroxidase-conjugated Protein A (GE Healthcare, Piscataway, NJ) for 1 hour at room temperature, followed by enhanced chemiluminescent detection. 293 cells were transfected with either human or rabbit EL cDNA constructs (pcDNA3.1) by lipofectamine LTX (5 µg DNA/100 mm plate). 48 hours later, the cell lysate was collected and subjected to Western blots probed with human EL mAb from Abcam (top), rEL polyclonal Ab (middle), and β-actin Ab (bottom).
H U V E C 2 9 3 c e l l 2 9 3 c e l l , h E L 2 9 3 c e l l , r E L hEL rEL E-actin 90 sequences of 20-mer oligonucleotides were designed by a linear "shot-gun" approach without targeting repeated sequences 22) . A rapid-throughput screen of the efficiency of 90 ASOs was performed using cultured normal rabbit hepatocytes to evaluate rEL mRNA expression after treatment with 150 nM of each ASO for 24 h by real-time RT-PCR. The top ten ASOs that showed the greatest potency in inhibiting rEL expression were selected and their inhibitory activity further assessed at different concentrations (25, 50, 150 , and 300 nM) (Fig. 2) . On the basis of IC50 values, four ASOs were tested for their rELinhibiting activity in JW rabbits in vivo. Finally, two rEL ASOs (designated as ISIS 440792 and ISIS 440825) were obtained that showed equal efficacy of inhibiting rEL expression of rabbit hepatocytes. Both ASOs had a uniform phosphorothioate backbone and a 20-base chimeric design with 2'-O-(methoxy)-ethyl (2'-MOE) modifications on the first five and last five bases 23) . These modifications enhanced their binding affinity to complementary sequences and their resistance to the action of nucleases. In the current study, ISIS 440825 was used for the injection experiment. A mismatch sequence (ISIS 141923), which has the same chemical composition as rEL ASOs but without complementarity to any known rabbit gene sequences, was used as a control.
Analysis of Plasma Lipids and Lipoproteins After ASO Treatment
Male JW rabbits and WHHLMI rabbits (4 months old) were intravenously injected with rEL ASO in saline solution (40 mg/kg), along with the mismatched control, weekly for 6 weeks. Plasma total cholesterol, triglycerides, and HDL-C were determined using Wako assay kits (Wako Pure Chemical Industries, Osaka, Japan), and lipoproteins were analyzed using high-performance liquid chromatography (HPLC) 17) by Skylight Biotech, Inc. (Tokyo, Japan) at the end of the experiment. After 6 weeks of rEL ASO treatment, all rabbits were sacrificed and rEL expression in the liver was determined by real-time RT-PCR and Western blotting 24) .
In situ Hybridization and Immunohistochemical Staining of Atherosclerotic Lesions
Aortic atherosclerotic lesions of WHHLMI rabbits (7 months old) and normal aortas of normal JW rabbits were quickly frozen in liquid nitrogen and then embedded in OCT compound solution. Serial frozen sections were used for in situ hybridization for rEL and immunohistochemical staining for macrophages and smooth muscle cells as described previbovine serum (Invitrogen). Fibroblasts between passages 2 and 5 were used for the current study. Mitotic chromosomes were prepared from rabbit fibroblasts as reported previously 19) . The cells were treated with colcemid (0.1 μg/mL) for 1.5 h and then harvested by trypsinization. After treatment with hypotonic solution (75 mM KCl:1% Na citrate, 1:1) for 6-10 min at 37 ℃, the cells were fixed with acetic acid:methanol (1:3), dropped onto ice-cold glass slides, and air-dried. The slides were kept at −80 ℃ until use. G-banding karyotyping was performed to identify each chromosome before FISH 20) . Karyotyping was performed using the CytoVision imaging system (Applied Imaging Corp., San Jose, CA) based on the standard karyotype and nomenclature of Oryctolagus cuniculus 21) . A BAC clone, LB1-130A10, which carried the rEL gene, was selected as the FISH probe for mapping the gene by screening rabbit BAC filter sets (LBNL-1 White Rabbit BAC Library from the BACPAC Resources, Oakland, CA) with the rEL cDNA sequences. The BAC DNA was isolated and purified using the QIAGEN Plasmid Midi Kit (QIAGEN) and labeled with biotin using the BioNick DNA Labeling System (Invitrogen, Carlsbad, CA). Karyotyped G-banded metaphase slides were treated with methanol/acetic acid fix solution, followed by incubation in 2x SSC at 73 ℃ for 2 min and 10% phosphate-buffered formalin at room temperature (RT) for 5 min. The slides were then dehydrated sequentially in 70%, 85%, and 100% ethanol at RT for 1 minute each. Approximately 10 μL hybridization mix solution (50% formamide, 10% dextran sulfate and 2XSSC) containing 1 μg labeled BAC DNA, 2 µg sheared rabbit genomic DNA, and 5 μg sheared salmon sperm DNA (Eppendorf, Hauppauge, NY) was denatured at 75 ℃ for 5 min, re-annealed at 37 ℃ for 30 min and then applied to a destained slide. The slides were incubated with the hybridization mix solution at 75 ℃ for 5 min before hybridization at 37 ℃ overnight. After hybridization, the slides were washed with 0.4x SSC/0.3% NP40 at 73 ℃ for 2 minutes and 2x SSC/0.1% NP40 at RT for 1 min. FISH signals were visualized by avidin-fluorescein staining (Roche, Indianapolis, IN) and DAPI Ⅱ counterstaining (Abbott Molecular, Des Plaines, IL), and analyzed using the CytoVision imaging system (Applied Imaging Corp., San Jose, CA). The rEL gene location was determined by comparing the FISH images with the corresponding karyotyped metaphase cells.
Preparation of rEL-Specific Antisense Oligonucleotides (ASOs)
On the basis of the cloned rEL cDNA sequences, rEL cDNA sequences, we assembled the rEL gene by serial BLAST search. The rEL gene contains 10 exons, similarly to human and mouse EL genes (Fig. 3B) . Our findings redefined the genomic structure of the rEL gene, which was recently predicted on the basis of the rabbit genome-sequencing data (www.ncbi.nlm. nih.gov/gene/100342293). In addition, FISH analysis revealed that the rEL gene was located in the chromosome 9q14.3-15.1 region (Fig. 4) , which is consistent with the predicted chromosomal location reported by the Broad Institute (www.ncbi.nlm.nih.gov/gene/ 100342293). Of note, rabbit chromosome 9 is homologous to human chromosome 18 25) . The EL molecular features of humans, rabbits, mice, and rats are summarized in Table 2 . In general, rEL possesses higher identity of both mRNA and protein sequences with human EL than mouse and rat EL. We also compared the rEL cDNA sequences with rabbit LPL and HL, both of which are important regulators in lipid metabolism 16, 17) . We cloned rabbit LPL cDNA and submitted it to Genbank (accession No.: NM_001177330) using the same method as used for rEL cloning. It was found that rEL protein was 49% homologous to rabbit LPL and 45% to rabbit HL.
Analysis of rEL mRNA in Tissues
Among 20 tissues, high expression of rEL mRNA ously 24) . The full protocol of in situ hybridization can be found in the Supplemental Methods.
Statistical Analysis
All values are expressed as the mean±SEM and statistical significance was determined. Student's t -test was used to compare the results. In all cases, statistical significance was set at p＜0.05.
Results
Cloning and Characterization of rEL cDNA
We successfully obtained the rEL cDNA sequences and submitted them to Genbank (accession No.: NM_001195638). The rEL cDNA contains an open reading frame of 1503 bp that codes for a 56.1 kDa protein. The amino acid sequence of rEL exhibits 85.4% identity with human EL (Fig. 3A) . The predicted rEL protein size is similar to that of human EL 2) . For example, the rEL contains a lipase domain (49-344 aa) and a PLAT/LH2 domain (347-483 aa) determined by Pfam family search (http://pfam.janelia.org/). The rEL enzymatically catalytic sites are S169, D193, and H274, which are conserved in human, mouse, and rat EL. 1-17 aa is the signal peptide predicted by online software (SIG-Pred: Signal Peptide Prediction). By the same strategy using the Ten kinds of ASOs were tested at different concentrations and their inhibiting effects on rEL mRNA expression were measured by real-time RT-PCR. ASO 440825 was selected for the in vivo study. UTC: untreated control group. expression of WHHLMI rabbits with that of chowfed normal JW rabbits. WHHLMI rabbits are genetically deficient in LDL receptors 26) and are characterized by having high levels of plasma total cholesterol due to the accumulation of LDLs, accompanied by a marked reduction of plasma HDL-C levels (Fig. 7A) . We first compared the rEL proteins in both pre-and post-heparin plasma from WHHLMI with that from normal JW rabbits by Western blotting. As shown in Fig. 7B , rEL proteins in normal JW rabbits were detectable in both pre-and post-heparin plasma. In WHHLMI rabbits, both pre-and post-heparin plasma contained more rEL proteins than normal JW rabbits. Moreover, we found that the hepatic rEL mRNA expression of WHHLMI rabbits was significantly higher than that of normal JW rabbits (Fig. 7C). was demonstrated in the liver, adrenal, testis, spleen, kidney, lung, bone marrow, and small intestine (Fig. 5) . This multiple expression pattern of rEL mRNA contrasted with the expression patterns of rabbit HL and LPL. Rabbit HL was exclusively expressed in the liver, whereas rabbit LPL was mainly expressed in the adipose, heart, and macrophages (Fig. 5) . To evaluate rEL expression in tissues, we also performed in situ hybridization of rEL mRNA expression in the liver and kidney. As shown in Fig. 6A and B, hepatocytes expressed rEL mRNA while, in the kidney, tubular epithelial cells along with small vessels showed detectable rEL mRNA signals.
rEL Expression in WHHLMI Rabbits
To study whether rEL functions are associated with low levels of plasma HDL, we compared the rEL (data not shown). Compared to control rabbits, rabbits injected with rEL ASOs did not show significant changes in plasma total cholesterol and triglycerides (data not shown); however, rEL-injected rabbits showed a slight (not statistically significant) elevation of plasma HDL-C levels compared with control rabbits (Fig. 8A) . In spite of these mild changes in HDL-C levels caused by rEL ASOs injection, large (＞ 12.1 nm) HDL cholesterol contents were significantly increased accompanied by a significant increase of
Effect of rEL Antisense Oligonucleotides on Plasma HDLs
To evaluate whether rEL modulates plasma HDL levels or HDL particles in vivo, we first intravenously injected rEL ASOs along with mismatched oligonucleotides (as a control) into normal chow-fed JW rabbits for 6 weeks. Rabbits injected with rEL ASOs did not show any changes in liver pathology and functions as serum levels of both alanine aminotransferase and aspartate aminotransferase were within normal ranges (Fig. 10A) . In aortic fatty-streak lesions, both endothelial cells and subendothelial macrophages showed abundant rEL mRNA expression. In the advanced lesions, macrophages along with some smooth muscle cells showed rEL expression (Fig. 10B) . rEL mRNA expression in arterial wall was also quantified by real-time RT-PCR. Compared with the hepatic expression of rEL, aortic endothelial cells isolated from normal JW rabbit aortas expressed 4% of hepatic rEL whereas intimal lesions of aortas from WHHLMI rabbits expressed 8% of hepatic rEL.
Discussion
In this study, we successfully cloned the rEL cDNA sequences and performed molecular characterization of the tissue expression of rEL in both normal and WHHLMI rabbits, an animal model appropriate for the study of human lipid metabolism and atherosclerosis 13, 27) . It was found that rEL exhibits high identity with human EL sequences compared with mouse and rat EL. The rEL is mapped to chromosome 9, which is homologous to human chromosome 18 25) . In addition, rEL showed high homology with rabbit LPL and HL, although they are quite different in tissue expression pattern and enzymatic activity. It has been reported that the major substrate for EL is HDL phospholipids but that for LPL is TG-rich lipoproteins, whereas HL can hydrolyze TG-rich lipoproteins, HDLs, and LDLs 11) . Although it is generally believed that EL is specifically expressed by vascular endothelial cells, EL expression has been reported in other tissues, such as the liver, lung, and kidney 1, 2) . Consistent with this observation, our studies revealed that many tissues expressed rEL in rabbits, similar to the EL expression patterns in human tissues determined by real-time RT-PCR (Zhang J., et al., unpublished observations). Hepatocytes and renal epithelial cells along with endothelial cells can express rEL mRNA, as shown by in situ hybridization. This multiple expression pattern of rEL suggests that rEL may exert diverse physiological functions in vivo. In tissues such as the liver, adrenal, and testis, rEL may mediate the uptake of lipoproteins for the synthesis of cholesterol and hormones. rEL can also hydrolyze HDLs to release free fatty acids, which can provide energy for those expressing tissues 28) . rEL proteins are detected in pre-heparin plasma but rEL contents are increased in WHHLMI rabbit plasma after injection with heparin, indicating that rEL conserved heparin-binding propphospholipids in these fractions in comparison with those of control rabbits, as shown by HPLC analysis (Fig. 8B and C) . Examination by real-time RT-PCR and Western blotting revealed that rEL ASO treatment resulted in about 50% reduction of hepatic rEL expression (both mRNA and protein) compared with control rabbits (Fig. 8D) . Furthermore, we injected rEL ASOs into WHHLMI rabbits, which had lower HDL-C levels than normal rabbits. As shown in Fig. 9 , treatment with rEL ASOs did not lead to a significant change in plasma HDL-C levels of WHHLMI rabbits, although a similar tendency was found in large-HDL fractions which were phospholipid-rich. noteworthy that many familial combined hyperlipidemic patients and homozygous familial hypercholesterolemic patients also have a reduction in HDL-C levels 31) , although the mechanisms for this phenomenon have not been completely elucidated. It will be interesting to investigate whether familial combined hyperlipidemic patients have high EL expression or whether increased EL expression is responsible for low HDL levels.
Secondly, we screened 90 candidate rEL ASOs using cultured rabbit hepatocytes and obtained two potent ASOs for in vivo study. Although rEL ASO injection resulted in a 50% reduction of hepatic rEL expression, plasma HDL-C levels were not significantly improved in both normal and WHHLMI rabbits, suggesting that either inhibition of hepatic rEL expression induced by rEL ASOs is not strong enough to increase plasma HDL levels or reduced hepatic rEL expression may be compensated by extra-hepatic rEL expression since rEL is expressed by multiple tissues, as shown in Northern blotting results. In EL KO mice 5) , plasma HDL-C was increased by 57% in LIPG −/− and 25% in LIPG
, which is much more prominent than in ASO-treated rabbits. It is not erties that can interact with heparan sulfate proteoglycans on the cellular surface 2) . To investigate whether rEL mediates HDL metabolism in vivo, we adopted two strategies. First, we analyzed rEL protein levels in the plasma of WHHLMI rabbits, which have concomitant hypercholesterolemia and low HDL levels. Our results showed that hepatic mRNA expressions of rEL in WHHLMI rabbits were higher than those of normal JW rabbits, which was coincidently associated with low plasma HDL-C levels. Interestingly, rEL proteins of pre-and post-heparin plasma in WHHLMI rabbits were simultaneously increased compared with those of normal rabbits. It is currently unknown, however, whether increased rEL expression in WHHLMI rabbits is a cause of low HDL-C levels or a consequence of high LDL levels. It is possible that high expression of rEL is caused by extensive aortic atherosclerotic lesions (namely, chronic inflammation) because EL is highly regulated by inflammation 29) . This phenomenon (high hepatic expression of EL) has not been observed in apoE KO and LDLr KO mice 11) . In fact, hepatic EL expression of these KO mice was downregulated while aortic EL was up-regulated 11, 30) . It is proteins. Using in situ hybridization, we demonstrated that rEL is widely expressed by vascular endothelial cells and macrophages in the lesions of WHHLMI rabbits, supporting the assertion that EL is involved in atherosclerosis 10) . "Dual functions" of EL (anti-atherogenic and pro-atherogenic) may depend upon the site of EL expression, such as hepatic vs. vascular cells of EL 3) . To examine these hypotheses and investigate the underlying molecular mechanisms in vivo, we need to develop transgenic rabbits overexpressing rEL in either the liver or macrophages. Efforts are now being directed towards creating EL transgenic rabbits in our laboratory in order to evaluate the effects of rEL on the development of atherosclerosis. In summary, we cloned rEL cDNA and investigated rEL expressions in both normal and WHHLMI rabbits. rEL is expressed in multiple tissues and plays an important role in HDL metabolism.
Acknowledgements
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